{"filing":{"accession_number":"0001104659-26-073431","cik":"0001400118","ticker":"SGMT","company_name":"Sagimet Biosciences Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"tm2617560d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/tm2617560d1_8k.htm"},"events":[{"id":10761,"run_id":9441,"accession_number":"0001104659-26-073431","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Tim Walbert, a Board member of Sagimet Biosciences Inc., tendered his resignation from the Board effective June 12, 2026, due to other commitments.","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":7157,"accession_number":"0001104659-26-073431","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Tim Walbert, a Board member of Sagimet Biosciences Inc., tendered his resignation from the Board effective June 12, 2026. The filing explicitly discloses a director's departure due to other commitments, with no disagreement cited. This is a clear executive departure event requiring 8-K disclosure under Item 5.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:18.382392+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":10762,"run_id":9441,"accession_number":"0001104659-26-073431","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Sagimet Biosciences held its 2026 Annual Meeting of Stockholders on June 12, 2026, with shareholders voting to elect four Class III directors (Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble) and ratify KPMG LLP as the independent registered public accountant.","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":7158,"accession_number":"0001104659-26-073431","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the final voting results from Sagimet Biosciences' 2026 Annual Meeting of Stockholders held on June 12, 2026. The section reports detailed vote tallies for two proposals: (a) election of four Class III directors (Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble) and (b) ratification of KPMG LLP as the independent registered public accountant. This is a textbook shareholder_vote_results disclosure, which is material as it confirms the composition of the board and auditor for the fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:18.382392+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7157,"accession_number":"0001104659-26-073431","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Tim Walbert, a Board member of Sagimet Biosciences Inc., tendered his resignation from the Board effective June 12, 2026. The filing explicitly discloses a director's departure due to other commitments, with no disagreement cited. This is a clear executive departure event requiring 8-K disclosure under Item 5.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:18.382392+00:00","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-12"},{"id":7158,"accession_number":"0001104659-26-073431","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the final voting results from Sagimet Biosciences' 2026 Annual Meeting of Stockholders held on June 12, 2026. The section reports detailed vote tallies for two proposals: (a) election of four Class III directors (Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble) and (b) ratification of KPMG LLP as the independent registered public accountant. This is a textbook shareholder_vote_results disclosure, which is material as it confirms the composition of the board and auditor for the fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:16:18.382392+00:00","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-12"}]}